Mortality from acquired heart disease during a 15 year period in the Russian Federation and the United States and an analysis of the factors influencing their formation

Authors: Semenov V.Yu. 1, Samorodskaya I.V. 2, Larina V.N. 3, Andreev E.M. 4

Company: 1 Bakoulev National Scientific and Practical Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Leninskiy prospekt, 8, Moscow, 119049, Russian Federation;
2 State Research Center for Preventive Medicine under the Ministry of Health of the Russian Federation, 10, Petroverigskiy pereulok, Moscow, 101990, Russian Federation;
3 Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, ulitsa Ostrovityanova, 1, Moscow, 117997, Russian Federation;
4 National Research University “Higher School of Economics”, Bol’shoy Trekhsvyatitel’skiy pereulok, 3, Moscow, 123022, Russian Federation

For correspondence:  Sign in or register.

Type:  Valvular heart disease


DOI: https://doi.org/10.24022/1997-3187-2017-11-3-235-246

For citation: Semenov V.Yu., Samorodskaya I.V., Larina V.N., Andreev E.M. Mortality from acquired heart disease during a 15 year period in the Russian Federation and the United States and an analysis of the factors influencing their formation. Kreativnaya kardiologiya (Creative Cardiology). 2017; 11 (3): 235–46 (in Russ.). DOI: 10.24022/1997- 3187-2017-11-2-235-246

Received / Accepted:  June 05, 2017 / June 16, 2017

Keywords: mortality in Russia mortality in USA acquired heart valve disorder heart valve

Full text:  

 

Abstract

Objective. To provide the comparative analysis of standardized mortality coefficients (SMC) of rheumatic and nonrheumatic mitral (MV) and aortic valve (AV) disorders in 15 years among adults over 30 in the RF and in the USA.

Material and methods. The analysis was performed in patients at the age of 30–49, and 50 and older for men and women separately. European standard population data in 2013 was used for mortality coefficients standardization. RF mortality rates were calculated on data of Federal State Statistics Service (1999–2013); USA rates – World Health Organization Mortality Database and Human Mortality Database (2000–2014).

Results. Summary SMC for MV and AV disorders at the age of 30–49 years was higher in RF comparing to USA (men – 1.8 and 0.6; women – 0.9 and 0.5 per 100 000 population), in the group over 50 years it was lower in RF comparing to USA (men – 9.9 and 26.5; women – 10.9 and 23.4). SMC of rheumatic disorders decreased significantly in RF during 15 years of analysis. SMC didn’t changed in USA and were more than 2 times lower comparing to RF in 2013. SMC of nonrheumatic MV and AV disorders were stable and significantly higher in USA at the age over 50 comparing to RF. The rates of SMC of nonrheumatic AV disorders in the mortality structure in men and women over 50 were 80.2 and 71.8% in USA and 25.1 and 13.1% in RF correspondingly. In spite of certain decrease in 15 years SMC of multiform valve disorders were significantly higher in RF (from 2.5 to 6.7 times in 2013 in different investigated groups).

Conclusion. There were significant differences in the mortality rates and structures from valves disorders in RF and USA. The essential decrease of SMC from rheumatic valve disorders in RF was registered. These differences were based on peculiarities of disease determination, health care organization, primary death’ cause detection and medical death certificates filling in.

References

  1. Schepin O.P., Medik V.A. Public Health and healthcare: National guide. Moscow: GEOTAR-Media;2013 (in Russ.).

  2. Lisitsyn Yu.P. Public health and health care: Manual.Moscow: GEOTAR-Media; 2010 (in Russ.).

  3. Kaykova L.V., Baraeva A.N. Planning in healthcare: Methodic recommendations. Yaroslavl’; 2011(in Russ.).

  4. Ordinance of the RF Government December dated19, 2016 No. 1403 “About the Program of the stateguaranties on free health care for citizens to year2017 and to planned period 2018 and 2019”.http://www.garant.ru/hotlaw/federal/1065565/(accessed January 15, 2017) (in Russ.).

  5. World Health Organization Mortality Database. Available at: http://www.who.int/healthinfo/statistics/ mortality_rawdata/en/ (accessed July 5, 2016).

  6. The Human Mortality Database. Available at: http://www.mortality.org/ (accessed July 5, 2016).

  7. Revision of the European Standard Population. Report of Eurostat's task force. Luxembourg; 2013. DOI: 10.2785/11470.

  8. Ozer O., Davutoglu V., Sari I., Akkoyun D.C., Sucu M. The spectrum of rheumatic heart disease in the southeastern anatolia endemic region: results from 1,900 patients. J. Heart Valve Dis. 2009; 18: 68–72.

  9. Coffey S., Cairns B.J., Iung B. The modern epidemiology of heart valve disease. Heart. 2016; 102 (1): 75–85. DOI: 10.1136/heartjnl-2014-307020.

  10. Bockeria O.L., Bazarsadaeva T.S. Sudden cardiacdeath and mitral and aortic valve disease. AnnalyAritmologii (Annals of Arrhythmology).2013; 10 (3):162–70. DOI: 10.15275/annaritmol.2013.3.6 (inRuss.).

  11. Lim W., Ramasamy A., Lloyd G., Bhattacharyya S. Meta-analysis of the impact of intervention versus symptom-driven management in asymptomatic severe aortic stenosis. Heart. 2017; 103: 268–72.

About Authors

  • Semenov Vladimir Yur'evich, Dr Med. Sc., Professor, Chief Physician of Institute for Coronar and Vascular Surgery, orcid.org/0000-0002-0278-5652;
  • Samorodskaya Irina Vladimirovna, Dr Med. Sc., Professor, Head of Laboratory, orcid.org/0000-0001-9320-1503;
  • Larina Vera Nikolaevna, Dr Med. Sc., Professor, orcid.org/0000-0001-7825-5597;
  • Andreev Evgeniy Mikhaylovich, Cand. Phys. Math. Sc., Head of Laboratory, orcid.org/0000-0002-1233-437X

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery